ES2115705T3 - Forma retardada para producto farmaceuticamente activo. - Google Patents

Forma retardada para producto farmaceuticamente activo.

Info

Publication number
ES2115705T3
ES2115705T3 ES93117141T ES93117141T ES2115705T3 ES 2115705 T3 ES2115705 T3 ES 2115705T3 ES 93117141 T ES93117141 T ES 93117141T ES 93117141 T ES93117141 T ES 93117141T ES 2115705 T3 ES2115705 T3 ES 2115705T3
Authority
ES
Spain
Prior art keywords
pharmaceutically active
active product
delayed form
chemical
delayed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93117141T
Other languages
English (en)
Inventor
Klaus Dr Harth
Hartmut Dr Hibst
Juergen Dr Dembowski
Reinhard Dr Spengler
Ernst Dr Flaig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of ES2115705T3 publication Critical patent/ES2115705T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Abstract

NUEVO MOLDE-RETARDO PARA SUSTANCIAS ACTIVAS FARMACEUTICAS, CARACTERIZADO POR UN NUCLEO QUE CONTIENE LA SUSTANCIA ACTIVA Y UNA CAPA DE CUBRICION RESISTENTE A LA ADHERENCIA, INHIBIDORA DE LA DIFUSION, CON UN ESPESOR DENTRO DEL MARGEN DE 0,01 HASTA 10 (MU)M, COMPUESTO DE UNA RED QUIMICA, QUE HA SIDO APLICADA POR UN METODO DE PRECIPITACION QUIMICO APOYADA POR PLASMA SOBRE EL SOPORTE, ASI COMO UN PROCESO PARA SU FABRICACION.
ES93117141T 1992-11-21 1993-10-22 Forma retardada para producto farmaceuticamente activo. Expired - Lifetime ES2115705T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4239244A DE4239244A1 (de) 1992-11-21 1992-11-21 Retard-Form für pharmazeutische Wirkstoffe

Publications (1)

Publication Number Publication Date
ES2115705T3 true ES2115705T3 (es) 1998-07-01

Family

ID=6473384

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93117141T Expired - Lifetime ES2115705T3 (es) 1992-11-21 1993-10-22 Forma retardada para producto farmaceuticamente activo.

Country Status (9)

Country Link
US (1) US5693340A (es)
EP (1) EP0599064B1 (es)
JP (1) JPH06211649A (es)
AT (1) ATE165735T1 (es)
CA (1) CA2103487C (es)
DE (2) DE4239244A1 (es)
DK (1) DK0599064T3 (es)
ES (1) ES2115705T3 (es)
MX (1) MX9307196A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981899A (en) 1997-01-17 1999-11-09 Balzers Aktiengesellschaft Capacitively coupled RF-plasma reactor
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
WO2000028969A2 (en) * 1998-11-18 2000-05-25 University Of Florida Methods for preparing coated drug particles and pharmaceutical formulations thereof
BR9805767A (pt) 1998-12-21 2000-08-08 Farmaceutico Caicara Ltda Lab Nova aplicaçào do ácido alfa-hidroxi-propiÈnico em medicina
US6406745B1 (en) 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
CZ20014319A3 (cs) * 1999-06-07 2002-04-17 Nanosphere, Inc. Způsob potahování jádrového materiálu a potahované částice
US20060045822A1 (en) * 2004-09-01 2006-03-02 Board Of Regents, The University Of Texas System Plasma polymerization for encapsulating particles
US20100297248A1 (en) * 2004-09-01 2010-11-25 Board Of Regents, The University Of Texas System Encapsulated particles for amorphous stability enhancement
JP2007246412A (ja) * 2006-03-14 2007-09-27 Serubakku:Kk 消化管用経口製剤とその製造方法および消化管用経口カプセル剤
US8088451B2 (en) 2008-03-13 2012-01-03 Board Of Regents, The University Of Texas System Covalently functionalized particles for synthesis of new composite materials
JP5466379B2 (ja) * 2008-06-30 2014-04-09 ツキオカフィルム製薬株式会社 フィルム状製剤及びフィルム状製剤の製造方法
WO2011146078A1 (en) * 2010-05-21 2011-11-24 Board Of Regents, The University Of Texas System Encapsulated particles for enteric release

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US5000886A (en) * 1987-05-26 1991-03-19 American Cyanamid Company Silicone-hardened pharmaceutical microcapsules and process of making the same
WO1990002546A1 (en) * 1988-09-09 1990-03-22 The Ronald T. Dodge Company Pharmaceuticals microencapsulated by vapor deposited polymers and method

Also Published As

Publication number Publication date
CA2103487C (en) 2003-10-28
ATE165735T1 (de) 1998-05-15
EP0599064B1 (de) 1998-05-06
DK0599064T3 (da) 1998-10-07
US5693340A (en) 1997-12-02
DE59308504D1 (de) 1998-06-10
EP0599064A1 (de) 1994-06-01
MX9307196A (es) 1994-05-31
CA2103487A1 (en) 1994-05-22
JPH06211649A (ja) 1994-08-02
DE4239244A1 (de) 1994-05-26

Similar Documents

Publication Publication Date Title
ES2115705T3 (es) Forma retardada para producto farmaceuticamente activo.
ES2044246T3 (es) Medicamentos con liberacion controlada del producto activo.
AR026560A1 (es) Recubrimiento
AR025428A1 (es) Formas de administracion de tramadol retardadas mediante un revestimiento que contiene la sustancia activa tramadol en forma de sacarinato de tramadol asicomo eventualmente otros excipientes
AR025962A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que los contienen
AR010414A1 (es) Metodo para preparar formas farmaceuticas solidas de administracion oral con liberacion controalda de la sustancia activa
IL109496A (en) Substituted pyrrolidin-3-yl-alkyl-piperidines process for their preparation and pharmaceutical compositions containing them
FI942074A (fi) nor-sappijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
DE69817587D1 (de) Aus einer vielzahl von kleineinheiten aufgebaute brausedosisform
ES2176209T3 (es) Preparacion farmaceutica oral liberable en el tracto digestivo inferior.
CA2145513A1 (en) Pharmaceutical Tablet Capable of Liberating One or More Drugs at Different Release Rates
AR028299A1 (es) Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
ES8308724A1 (es) Procediento para la fabricacion de un articulo solido coloreado portador al memos de una talla en resalte o sebresaliente
ES2091654T3 (es) Sistema efervescente que contiene un ingrediente activo farmaceutico sensible a alcalis y/o metales, y procedimiento para su produccion.
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
AR019145A1 (es) Proceso para aplicar un estrato a una unidad farmaceutica, forma de dosis de unidad, y aparato para estratificar una unidad farmaceutica.
TR200401436T4 (tr) Monotiyogliserol, L-sistem veya tiyoglikolik asitle birlikte pemetrexed içeren farmasötik bileşim
AR013967A1 (es) UNA FORMULACION MEDICAMENTOSA PARA LA ADMINISTRACION ORAL DE PELLET DE DIFUSION CONTROLADA QUE TIENE LIBERACION CONTROLADA DE UN COMPUESTO ACTIVO QUE ES SELECCIONADO DEL ACIDO 1-CICLOPROPIL-7- [(S,S)-2,8-DIAZABICICLO [4.3.0] NON-8-IL ]-6-FLuOR-1,4-DIHIDRO-8-METOXI-4-OXO-3-QUINOLON CARBOXILICO O SALE
DE60043442D1 (de) Ner aktiven phase und einer inaktiven phase
DK1200325T3 (da) Fremgangsmåde til fremstilling af regenerative fotoelektrokemiske enkeltcelle- og flercelleindretninger
GB0010446D0 (en) Pharmaceutical formulation
CA2344686A1 (en) High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
TW200716199A (en) Lozenge production process
ES2218217T3 (es) Laminas plasticas, particularmente para ser utilizadas en un sistema terapeutico dermico o transdermico.
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 599064

Country of ref document: ES